<div id="readability-page-1"><p>In a report released yesterday, Lee Hambright from Bernstein maintained a Buy rating on Medtronic, with a price target of <span id="expert-recommendation-target">$111.00</span>. The company’s shares closed yesterday at $99.87.</p><h3>Claim 50% Off TipRanks Premium and Invest with Confidence </h3><ul><li>Unlock  hedge-fund level data  and  powerful investing tools  designed to help you make smarter, sharper decisions  </li><li> Stay ahead of the market with  the latest news and analysis  so your portfolio is always positioned for maximum potential</li></ul> <p>According to TipRanks, Hambright is a 4-star analyst with an average return of <span>6.9%</span> and a 61.18% success rate. Hambright covers the Healthcare sector, focusing on stocks such as Intuitive Surgical, Insulet, and Medtronic.</p> <p>The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Medtronic with a $111.94 average price target, representing a 12.09% upside. In a report released on December 11, Citi also maintained a Buy rating on the stock with a $117.00 price target.</p></div>

<p>Bernstein's Lee Hambright maintained a Buy rating on Medtronic (MDT) with a price target of $111.00. Medtronic's shares closed at $99.87. Hambright, a 4-star analyst, has a 6.9% average return and a 61.18% success rate. The consensus rating for Medtronic is Moderate Buy with a $111.94 average price target, indicating a 12.09% upside. Citi also maintained a Buy rating with a $117.00 price target.</p>

Medtronic (MDT) Receives a Buy from Bernstein